Authors

• Emile Otsubo
• Daniela Pirri
• Mariana Norton (ORCID: https://orcid.org/0000-0002-9652-716X)
• Cecilia Dunsterville
• Brian Y.H. Lam (ORCID: https://orcid.org/0000-0002-3638-9025)
• Bryn M. Owen (ORCID: https://orcid.org/0000-0001-5296-7553)
• Shay Giles
• Ben Jones (ORCID: https://orcid.org/0000-0003-0461-2584)
• Gavin A. Bewick (ORCID: https://orcid.org/0000-0002-4335-8403)
• Phyllis Phuah (ORCID: https://orcid.org/0000-0003-2355-0358)
• Pei-En Chung
• A G Irene Roberts
• Aylin Carla Hanyaloglu (ORCID: https://orcid.org/0000-0003-4206-737X)
• Sofia Aleksashina
• Kevin G Murphy
• Fiona M. Gribble
• Rafal Karwowski
• Frank Reimann
• Leah Meyer

Institutions

• King's College London (GB)
• Hammersmith Hospital (GB)
• Wellcome/MRC Institute of Metabolic Science (GB)
• Imperial College London (GB)

Publication Details

Journal

Diabetologia

Published

2026-03-04

DOI

https://doi.org/10.1007/s00125-026-06688-4

Primary Topic

Gut microbiota and health

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Eli Lilly and Company
• Wellcome Trust
• Cancer Research UK
• National Institute for Health and Care Research
• Diabetes UK
• Imperial College London
• Medical Research Council
• Biotechnology and Biological Sciences Research Council
• Cancer Research UK Cambridge Institute, University of Cambridge